◀ Back to PAF1

PAF1 — PVR

Text-mined interactions from Literome

Bellan et al., Am J Physiol 1992 : Pulmonary vascular resistance (PVR) was increased, systemic vascular resistance ( SVR ) was reduced, and changes in PVR and SVR in response to PAF were blocked by the novel PAF receptor antagonist, BN 50730
Oral et al., J Cardiovasc Electrophysiol 2004 (Atrial Fibrillation...) : PV isolation has a lower efficacy in patients with vagotonic PAF than in patients with adrenergic or random episodes of PAF, suggesting that the PVs less often play an important role in vagotonic PAF
McCormack et al., Crit Care Med 1990 (Anoxia...) : Additionally, indomethacin ( 2 mg/kg followed by 2 mg/kg.h iv ) treatment of the animals attenuated the PAF induced increase in PVR
Sánchez Crespo et al., Agents Actions 1981 : Therefore, an experimental approach using 57Co and 113Sn radiolabelled microspheres was developed to evaluate the effect of PAF on cardiac output ( CO ), peripheral vascular resistance (PVR) and redistribution of CO among organs